ESTRO Multidisciplinary Management of Breast Cancer 2017

Previous Page

Next Page

Page Background

Adjuvant systemic therapy is a “blind”

procedure: It is administered after the

only opportunity for monitoring for

effectiveness has been eliminated

G.N.Hortobagyi, SABCS 2012